Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes. / Kwapiszewski, Radoslaw; Kwapiszewska, Karina; Kutter, Jörg P; Brzozka, Zbigniew.

In: Analytica Chimica Acta, Vol. 853, 01.01.2015, p. 702-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kwapiszewski, R, Kwapiszewska, K, Kutter, JP & Brzozka, Z 2015, 'Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes', Analytica Chimica Acta, vol. 853, pp. 702-9. https://doi.org/10.1016/j.aca.2014.08.042

APA

Kwapiszewski, R., Kwapiszewska, K., Kutter, J. P., & Brzozka, Z. (2015). Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes. Analytica Chimica Acta, 853, 702-9. https://doi.org/10.1016/j.aca.2014.08.042

Vancouver

Kwapiszewski R, Kwapiszewska K, Kutter JP, Brzozka Z. Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes. Analytica Chimica Acta. 2015 Jan 1;853:702-9. https://doi.org/10.1016/j.aca.2014.08.042

Author

Kwapiszewski, Radoslaw ; Kwapiszewska, Karina ; Kutter, Jörg P ; Brzozka, Zbigniew. / Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes. In: Analytica Chimica Acta. 2015 ; Vol. 853. pp. 702-9.

Bibtex

@article{7f6ba8d6b95e480ab8c440b5b4bb5c82,
title = "Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes",
abstract = "Lysosomal storage diseases are chronic, progressive and typically have a devastating impact on the patient and the family. The diagnosis of these diseases is still a challenge, however, even for trained specialists. Accurate diagnostic methods and high-throughput tools that could be readily incorporated into existing screening laboratories are urgently required. We propose a new method for measuring the activity of lysosomal enzymes using a microfluidic device. The principle of the method is the fluorometric determination of a protonated form of 4-methylumbelliferone directly in the enzymatic mixture. Compared to the standard diagnostic protocols, the method eliminates the necessity to add alkaline buffer to stop the enzymatic reaction, and thus, the number of analytical steps is reduced. The system allows for on-chip short-term incubation of the enzymatic reagents, leading to a much simplified analytical procedure and a significantly shortened processing time. We measured the activity of β-galactosidase in RPMI-1788 human B lymphocytes and in isolated leukocytes from healthy adults. The method shows a good agreement with the standard diagnostic method. The agreement was confirmed by statistical analysis including construction of a Bland-Altman plot. The approach presented can be an alternative for the currently used diagnostic procedures. The method developed has a potential for the implementation into complex microfluidic devices thus becoming a powerful tool for a high-throughput and multiplex screening of newborns.",
author = "Radoslaw Kwapiszewski and Karina Kwapiszewska and Kutter, {J{\"o}rg P} and Zbigniew Brzozka",
note = "Copyright {\textcopyright} 2014 Elsevier B.V. All rights reserved.",
year = "2015",
month = jan,
day = "1",
doi = "10.1016/j.aca.2014.08.042",
language = "English",
volume = "853",
pages = "702--9",
journal = "Analytica Chimica Acta",
issn = "0003-2670",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Three-layer poly(methyl methacrylate) microsystem for analysis of lysosomal enzymes for diagnostic purposes

AU - Kwapiszewski, Radoslaw

AU - Kwapiszewska, Karina

AU - Kutter, Jörg P

AU - Brzozka, Zbigniew

N1 - Copyright © 2014 Elsevier B.V. All rights reserved.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Lysosomal storage diseases are chronic, progressive and typically have a devastating impact on the patient and the family. The diagnosis of these diseases is still a challenge, however, even for trained specialists. Accurate diagnostic methods and high-throughput tools that could be readily incorporated into existing screening laboratories are urgently required. We propose a new method for measuring the activity of lysosomal enzymes using a microfluidic device. The principle of the method is the fluorometric determination of a protonated form of 4-methylumbelliferone directly in the enzymatic mixture. Compared to the standard diagnostic protocols, the method eliminates the necessity to add alkaline buffer to stop the enzymatic reaction, and thus, the number of analytical steps is reduced. The system allows for on-chip short-term incubation of the enzymatic reagents, leading to a much simplified analytical procedure and a significantly shortened processing time. We measured the activity of β-galactosidase in RPMI-1788 human B lymphocytes and in isolated leukocytes from healthy adults. The method shows a good agreement with the standard diagnostic method. The agreement was confirmed by statistical analysis including construction of a Bland-Altman plot. The approach presented can be an alternative for the currently used diagnostic procedures. The method developed has a potential for the implementation into complex microfluidic devices thus becoming a powerful tool for a high-throughput and multiplex screening of newborns.

AB - Lysosomal storage diseases are chronic, progressive and typically have a devastating impact on the patient and the family. The diagnosis of these diseases is still a challenge, however, even for trained specialists. Accurate diagnostic methods and high-throughput tools that could be readily incorporated into existing screening laboratories are urgently required. We propose a new method for measuring the activity of lysosomal enzymes using a microfluidic device. The principle of the method is the fluorometric determination of a protonated form of 4-methylumbelliferone directly in the enzymatic mixture. Compared to the standard diagnostic protocols, the method eliminates the necessity to add alkaline buffer to stop the enzymatic reaction, and thus, the number of analytical steps is reduced. The system allows for on-chip short-term incubation of the enzymatic reagents, leading to a much simplified analytical procedure and a significantly shortened processing time. We measured the activity of β-galactosidase in RPMI-1788 human B lymphocytes and in isolated leukocytes from healthy adults. The method shows a good agreement with the standard diagnostic method. The agreement was confirmed by statistical analysis including construction of a Bland-Altman plot. The approach presented can be an alternative for the currently used diagnostic procedures. The method developed has a potential for the implementation into complex microfluidic devices thus becoming a powerful tool for a high-throughput and multiplex screening of newborns.

U2 - 10.1016/j.aca.2014.08.042

DO - 10.1016/j.aca.2014.08.042

M3 - Journal article

C2 - 25467521

VL - 853

SP - 702

EP - 709

JO - Analytica Chimica Acta

JF - Analytica Chimica Acta

SN - 0003-2670

ER -

ID: 129699319